Publications by authors named "Kelly Downing"

Claim this Profile
C
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Yoko Kojima, Kelly Downing, Ramendra Kundu, Clint Miller, Frederick Dewey

J Clin Invest· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.
Vivek Nanda, Kelly P Downing, Jianqin Ye, Sophia Xiao, Yoko Kojima

Circ Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
Yoko Kojima, Kelly Downing, Ramendra Kundu, Clint Miller, Frederick Dewey

J Clin Invest· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.
Kelly P Downing, Kevin T Nead, Yoko Kojima, Themistocles Assimes, Lars Maegdefessel

Vasc Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.
Nicholas J Leeper, Azad Raiesdana, Yoko Kojima, Ramendra K Kundu, Henry Cheng, Kelly P Downing

Arterioscler Thromb Vasc Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis